Blister Pack Container with Adhesive Sealing for Drug Diversion Prevention
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The misuse and disposal of unused pharmaceutical products, particularly pain management drugs and transdermal analgesic patches, pose health risks due to potential diversion and environmental concerns, with existing disposal methods being costly and inefficient.
Innovation Solution
A pharmaceutical product supply system featuring a container with a pharmaceutical product receiver, adhesive, and release liner, allowing the container to transition from a first configuration where receptacles are accessible to a second configuration where they are inaccessible, securing the contents for safe disposal by locking the receiver within the container.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of operation
If pharmaceutical products are disposed of in the trash, then disposal is simple and convenient, but there is a risk of diversion and misuse by individuals other than the prescribed patient
Solution Approach 1:
The container is pre-configured with adhesive surfaces and release liners that enable secure sealing. The adhesive is applied to the container walls and the release liner is positioned over it, ready to seal the container when removed, preventing future access to the pharmaceutical product without requiring complex disposal procedures
2Ease of operation
If used transdermal analgesic patches are flushed down the toilet, then disposal is simple, but drug product may enter the water supply causing environmental contamination
Solution Approach 1:
The adhesive is extracted from its initial position on the container and repositioned to seal the container completely. The release liner is removed to expose the adhesive, which then secures the container in a sealed state, preventing pharmaceutical products from entering the environment through improper disposal methods like flushing
3Object-affected harmful factors
If take-back programs are used for disposal, then secure disposal is achieved, but the process is costly and requires multiple actions by the patient at multiple times
Solution Approach 1:
The container is designed to be self-sealing through its adhesive and release liner mechanism. The patient simply removes the release liner to activate the adhesive, which automatically seals the container without requiring external services or multiple actions, making secure disposal simple and immediate
4Object-affected harmful factors
If the container is sealed to prevent access, then security against misuse is improved, but the container must be opened again for legitimate use of remaining pharmaceutical product
Solution Approach 1:
The container configuration is dynamic rather than static. The adhesive and release liner system allows the container to transition between an open state (for legitimate use) and a sealed state (for security). The release liner can be removed to seal the container, and the design allows for controlled access when needed, adapting to different usage phases
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The system effectively reduces the risk of misuse and environmental contamination by ensuring that unused pharmaceutical products remain inaccessible after partial use, facilitating secure and environmentally friendly disposal.
Implementation Method 1
The adhesive is provided on the container, on the pharmaceutical product receiver, or on each of the container and the pharmaceutical product receiver
Data Source
AI summary
A pharmaceutical product supply is disclosed in the form of a container, a pharmaceutical product receiver, pharmaceutical product, an adhesive, and at least one release liner. The pharmaceutical product receiver includes a plurality of receptacles for pharmaceutical product. The container is initially disposed in a first configuration where all of the pharmaceutical product receiver receptacles may be accessible. The container is thereafter disposable in a second configuration where no covering for any of the pharmaceutical product receiver receptacles is accessible through any openable access incorporated by the container. One or more release liners may be moved to expose adhesive for disposing and retaining the container in its second configuration. The noted second configuration of the container facilitates disposal of the pharmaceutical product supply (e.g., now being in a form that should reduce the potential for gaining access to any remaining pharmaceutical product still enclosed within the pharmaceutical product receiver).